| RS1569498896 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569499010 |
COL4A5
|
Health Risk |
Likely pathogenic |
COL4A5-related disorder, COL4A5-related disorder |
| RS1569499015 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569499064 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS1569499310 |
GATA1
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS1569499366 |
GATA1
|
Health Risk |
Pathogenic |
GATA binding protein 1 related thrombocytopenia with dyserythropoiesis, Diamond-Blackfan anemia |
| RS1569504056 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569504068 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569504072 |
COL4A5
|
Health Risk |
Likely pathogenic |
Alport syndrome, Alport syndrome |
| RS1569504092 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS1569505374 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569505525 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS1569505604 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569505613 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569505758 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569505771 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, COL4A5-related disorder |
| RS1569505812 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS1569507398 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS1569507511 |
SLC9A7
|
Health Risk |
Likely pathogenic |
SLC9A7-related neurodevelopmental disorder, Intellectual developmental disorder |
| RS1569507535 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569507550 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS1569507848 |
STAG2
|
Health Risk |
Pathogenic |
Mullegama-Klein-Martinez syndrome, Holoprosencephaly 13 |
| RS1569508169 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS1569508360 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569508382 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569508899 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569508922 |
ALG13
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS1569508998 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569509136 |
HUWE1
|
Health Risk |
Likely pathogenic |
Trigonocephaly-short stature-developmental delay syndrome, Intellectual disability |
| RS1569509210 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS1569509234 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569509257 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569509307 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS1569509333 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS1569509371 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569510978 |
STAG2
|
Health Risk |
Likely pathogenic |
STAG2-related disorder, STAG2-related disorder |
| RS1569511477 |
STAG2
|
Health Risk |
Likely pathogenic |
STAG2-related disorder, Mullegama-Klein-Martinez syndrome |
| RS1569511572 |
SLC35A2
|
Health Risk |
Pathogenic |
SLC35A2-congenital disorder of glycosylation, SLC35A2-congenital disorder of glycosylation |
| RS1569512576 |
SBF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1569512722 |
STAG2
|
Health Risk |
Pathogenic |
Mullegama-Klein-Martinez syndrome, Mullegama-Klein-Martinez syndrome |
| RS1569512941 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS1569513017 |
ATRX
|
Health Risk |
Pathogenic |
Global developmental delay, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS1569513021 |
ATRX
|
Health Risk |
Pathogenic |
Intellectual disability-hypotonic facies syndrome, X-linked |
| RS1569513495 |
SBF1
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS1569515457 |
ATRX
|
Health Risk |
Likely pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS1569515486 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1569515507 |
STAG2
|
Health Risk |
Likely pathogenic |
Mullegama-Klein-Martinez syndrome, STAG2-related disorder |
| RS1569515729 |
STAG2
|
Health Risk |
Likely pathogenic |
STAG2-related disorder, STAG2-related disorder |
| RS1569516166 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1569517717 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1A |
| RS1569517943 |
COL6A1
|
Health Risk |
Likely pathogenic |
Ullrich congenital muscular dystrophy 1A, Ullrich congenital muscular dystrophy 1A |
| RS1569518070 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1569518119 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1569518138 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ullrich congenital muscular dystrophy 1A, Bethlem myopathy 1A |
| RS1569518481 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1569518677 |
COL6A1
|
Health Risk |
Likely pathogenic |
Ullrich congenital muscular dystrophy 1A, Ullrich congenital muscular dystrophy 1A |
| RS1569518725 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1569518771 |
COL6A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 1A, Ullrich congenital muscular dystrophy 1A |
| RS1569519030 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1569519109 |
COL6A1
|
Health Risk |
Pathogenic |
— |
| RS1569519202 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1569519211 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1569520709 |
STAG2
|
Health Risk |
Pathogenic |
Mullegama-Klein-Martinez syndrome, Mullegama-Klein-Martinez syndrome |
| RS1569520797 |
ALG13
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 36 |
| RS1569521573 |
SCO2
|
Health Risk |
Pathogenic |
— |
| RS1569523436 |
WDR45
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1569523457 |
WDR45
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1569523468 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1569523500 |
WDR45
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid cancer, nonmedullary |
| RS1569523502 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1569523537 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1569523544 |
WDR45
|
Health Risk |
Pathogenic |
X-linked cerebral-cerebellar-coloboma syndrome syndrome, X-linked cerebral-cerebellar-coloboma syndrome syndrome |
| RS1569523562 |
WDR45
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1569523565 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1569523728 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1569525357 |
SLC9A6
|
Health Risk |
Likely pathogenic |
Christianson syndrome, Christianson syndrome |
| RS1569525894 |
SLC9A6
|
Health Risk |
Likely pathogenic |
— |
| RS1569526122 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Thyroid cancer |
| RS1569526156 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1569526579 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569527111 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative syndrome, X-linked lymphoproliferative syndrome |
| RS1569528090 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1569528101 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569528138 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569528833 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS1569529545 |
MYL9
|
Health Risk |
Conflicting classifications of pathogenicity |
Megacystis-microcolon-intestinal hypoperistalsis syndrome 4, Visceral myopathy 1 |
| RS1569529565 |
FOXP3
|
Health Risk |
Likely pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS1569529715 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS1569530432 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Neuromuscular disease caused by qualitative or quantitative defects of dystrophin |
| RS1569530437 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS1569530588 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, Cardiovascular phenotype |
| RS1569531639 |
RP2
|
Health Risk |
Pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS1569533147 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569533321 |
ATRX
|
Health Risk |
Likely pathogenic |
— |
| RS1569533871 |
KDM6A
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS1569533965 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569534160 |
APOL1
|
Health Risk |
risk factor |
Focal segmental glomerulosclerosis 4, susceptibility to |
| RS1569534805 |
MYH9
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS1569535642 |
ATRX
|
Health Risk |
Pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS1569536694 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Intellectual disability-hypotonic facies syndrome |